Brian Jarman
Abstract
Both aspirin and warfarin are effective methods of secondary prevention after myocardial infarction, but their role in primary prevention of ischemic heart disease (IHD) remains unsettled. In this trial from the U.K., 5,085 men aged 45 to 69 and at high risk for IHD were randomized to low-dose aspirin (75 mg daily), low-dose warfarin …
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Both aspirin and warfarin are effective methods of secondary prevention after myocardial infarction, but their role in primary prevention of ischemic heart disease (IHD) remains unsettled. In this trial from the U.K., 5,085 men aged 45 to 69 and at high risk for IHD were randomized to low-dose aspirin (75 mg daily), low-dose warfarin …
Key concepts: Aspirin, Warfarin, Medicine, Myocardial infarction, Secondary prevention, Primary prevention, Internal medicine, Cardiology